Just now post the wrong ticker , ARGX is the correct with good news
$argenx SE(ARGX.US$argenx Reports Positive Topline Data from ADHERE Study of VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
102514180 : Wow... Up $92 ARGX